Investigation of serotype distribution and resistance genes profile in group B Streptococcus isolated from pregnant women: a Chinese multicenter cohort study

Apmis ◽  
2016 ◽  
Vol 124 (9) ◽  
pp. 794-799 ◽  
Author(s):  
Yuzhong Yan ◽  
Hua Hu ◽  
Tingyan Lu ◽  
Huiqing Fan ◽  
Yan Hu ◽  
...  
Keyword(s):  
Cohort Study ◽  
Pregnant Women ◽  
Resistance Genes ◽  
Group B Streptococcus ◽  
Serotype Distribution ◽  
Multicenter Cohort Study ◽  
Multicenter Cohort ◽  
Group B

scholarly journals Analysis of virulence factors and antibiotic resistance genes in Group B Streptococcus from clinical samples

2020 ◽  
Author(s):  
Raymond Mudzana ◽  
Rooyen T Mavenyengwa ◽  
Muchaneta Gudza-Mugabe
Keyword(s):  
Antibiotic Resistance ◽  
Pregnant Women ◽  
Virulence Factors ◽  
Resistance Genes ◽  
Virulence Genes ◽  
Group B Streptococcus ◽  
Antibiotic Resistance Genes ◽  
Virulence Gene ◽  
Clinical Samples ◽  
Group B

Abstract Background: Streptococcus agalacticae is one of the most important causative agents of serious infections among neonates. Group B Streptococcus (GBS) virulence factors are important in the development of vaccines, whilst antibiotic resistance genes are necessary in understanding the resistance mechanisms used by these pathogens. This study was carried out to identify the virulence genes and antibiotic resistance genes associated with GBS isolated from pregnant women.Methods: A total of 43 GBS isolates were obtained from vaginal samples that were collected from all HIV positive and HIV negative women who were 13-35 weeks pregnant attending Antenatal Care at both Chitungwiza and Harare Central Hospitals in Zimbabwe. Identification tests of GBS isolates was done using standard bacteriological methods including molecular tests. Antibiotic susceptibility testing using 3 antibiotics was done using the modified Kirby-Bauer method. The boiling method was used to extract DNA and Polymerase Chain Reaction (PCR) was used to screen for 13 genes in the isolates. Data was fed into SPSS 24.0 and the Spearman rank correlation test used to determine any correlation among genes.Results: Nine distinct virulence gene profiles were identified. The profiles hly-scpB-bca-rib 37.2% (16/43) and hly-scpB-bca 18.6% (8/43) were common among GBS isolates. The following virulence gene frequencies were obtained namely hly 97.8% (42/43), scpB 90.1% (39/43), bca 86.0% (37/43), rib 69.8% (30/43) and bac 11.6% (5/43). Antibiotic resistance genes showed high frequencies for tetM 97.6% (41/42) and low frequencies for ermB 34.5% (10/29), ermTR 10.3% (3/29), mefA 3.4% (1/29), tetO 2.4% (1/42) and linB 0% (0/35). The atr housekeeping gene amplification yielded 100% (43/43) positive results, whilst the mobile genetic element IS1548 yielded a low 9.3% (4/43).Conclusion: The study showed a high prevalence of multiple virulence genes hly, scpB, bca and rib in S. agalactiae strains isolated from pregnant women. Tetracycline resistance was found to be predominantly caused by the tetM gene, whilst macrolide resistance was predominantly due to the presence of erm methylase, with the ermB gene being more prevalent. It was also observed that in vitro phenotypic resistance is not always accurately predicted by resistance genotypes.

scholarly journals Group B streptococcus colonization, antibiotic susceptibility, and serotype distribution among Saudi pregnant women

2020 ◽  
Vol 52 (1) ◽  
pp. 70
Author(s):  
Amr Mohamed Mohamed ◽  
Mubashir Ahmad Khan ◽  
Aftab Faiz ◽  
Jawwad Ahmad ◽  
Elsheikh Babiker Khidir ◽  
...  
Keyword(s):  
Pregnant Women ◽  
Antibiotic Susceptibility ◽  
Group B Streptococcus ◽  
Serotype Distribution ◽  
Group B

scholarly journals Group B Streptococcus colonization rate and serotype distribution among pregnant women and their newborns at Adama Hospital Medical College, Ethiopia

2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Musa Mohammed Ali ◽  
Daniel Asrat ◽  
Demissie Assegu Fenta ◽  
Tolossa Eticha Chaka ◽  
Yimtubezinash Woldeamanuel
Keyword(s):  
Pregnant Women ◽  
Group B Streptococcus ◽  
Colonization Rate ◽  
Serotype Distribution ◽  
Medical College ◽  
Hospital Medical ◽  
Group B

scholarly journals Group B streptococcus (GBS) colonization and disease among pregnant women: a historical cohort study

2017 ◽  
Vol 217 (6) ◽  
pp. 731
Author(s):  
James M. Edwards ◽  
Clara Wynn ◽  
Nora Watson ◽  
Chris Focht ◽  
Christopher A. Todd ◽  
...  
Keyword(s):  
Cohort Study ◽  
Pregnant Women ◽  
Group B Streptococcus ◽  
Historical Cohort ◽  
Historical Cohort Study ◽  
Group B

Serotype distribution and antibiotic susceptibility of group B streptococci in pregnant women

2009 ◽  
Vol 138 (7) ◽  
pp. 979-981 ◽  
Author(s):  
A. DHANOA ◽  
R. KARUNAKARAN ◽  
S. D. PUTHUCHEARY
Keyword(s):  
Pregnant Women ◽  
Neonatal Sepsis ◽  
Antibiotic Susceptibility ◽  
Group B Streptococcus ◽  
Prevention Strategies ◽  
Serotype Distribution ◽  
Group B Streptococci ◽  
Birth Canal ◽  
Group B

SUMMARYGroup B streptococcus (GBS) is a leading cause of neonatal sepsis and is usually acquired via the woman's birth canal. GBS serotypes isolated from 200 pregnant women were determined. Serotypes V (19%) and VI (17%) were the most frequent followed by serotypes III (12%), Ia (11·5%) and IV (10%); 17% of the strains were non-typable. All isolates were susceptible to penicillin, 96% to erythromycin and 97·5% to clindamycin. The emergence of new GBS serotypes has important implications for vaccine prevention strategies.

scholarly journals Developing a serocorrelate of protection against invasive group B streptococcus disease in pregnant women: a feasibility study

2019 ◽  
Vol 23 (67) ◽  
pp. 1-40 ◽  
Author(s):  
Clara Carreras-Abad ◽  
Madeleine Cochet ◽  
Tom Hall ◽  
Laxmee Ramkhelawon ◽  
Asma Khalil ◽  
...  
Keyword(s):  
Pregnant Women ◽  
Feasibility Study ◽  
Group B Streptococcus ◽  
Serotype Distribution ◽  
Invasive Group ◽  
Streptococcal Disease ◽  
Group B Streptococcal Disease ◽  
Intrapartum Antibiotic ◽  
Group B ◽  
Operational Aspects

Background Group B streptococcus is the leading cause of infection in infants. Currently, intrapartum antibiotic prophylaxis is the major strategy to prevent invasive group B streptococcus disease. However, intrapartum antibiotic prophylaxis does not prevent maternal sepsis, premature births, stillbirths or late-onset disease. Maternal vaccination may offer an alternative strategy. Multivalent polysaccharide protein conjugate vaccine development is under way and a serocorrelate of protection is needed to expedite vaccine licensure. Objectives The ultimate aim of this work is to determine the correlate of protection against the major group B streptococcus disease-causing serotypes in infants in the UK. The aim of this feasibility study is to test key operational aspects of the study design. Design Prospective cohort study of pregnant women and their infants in a 6-month period (1 July to 31 December 2018). Setting Five secondary and tertiary hospitals from London and South England. National iGBS disease surveillance was conducted in all trusts in England and Wales. Participants Pregnant women aged ≥ 18 years who were delivering at one of the selected hospitals and who provided consent during the study period. There were no exclusion criteria. Interventions No interventions were performed. Main outcome measures (1) To test the feasibility of collecting serum at delivery from a large cohort of pregnant women. (2) To test the key operational aspects for a proposed large serocorrelates study. (3) To test the feasibility of collecting samples from those with invasive group B streptococcus. Results A total of 1823 women were recruited during the study period. Overall, 85% of serum samples were collected at three sites collecting only cord blood. At the two sites collecting maternal, cord and infant blood samples, the collection rate was 60%. A total of 614 women were screened for group B streptococcus with a colonisation rate of 22% (serotype distribution: 30% III, 25% Ia, 16% II, 14% Ib, 14% V and 1% IV). A blood sample was collected from 34 infants who were born to colonised women. Maternal and infant blood and the bacterial isolates for 15 newborns who developed invasive group B streptococcal disease during the study period were collected (serotype distribution: 29% III, 29% II, 21% Ia, 7% Ib, 7% IV and 7% V). Limitations Recruitment and sample collection were dependent on the presence of research midwives rather than the whole clinical team. In addition, individualised consent limited the number of women who could be approached each day, and site set-up for the national surveillance study and the limited time period of this feasibility study limited recruitment of all eligible participants. Conclusions We have verified the feasibility of collecting and processing rectovaginal swabs and blood samples in pregnant women, as well as samples from those with invasive group B streptococcal disease. We have made recommendations for the recruitment of cases within the proposed GBS3 study and for controls both within GBS3 and as an extension of this feasibility study. Future work A large case–control study comparing specific immunoglobulin G levels in mothers whose infants develop invasive group B streptococcal disease with those in colonised mothers whose infants do not develop invasive group B streptococcal disease is recommended. Trial registration Current Controlled Trials ISRCTN49326091; IRAS project identification number 246149/REC reference number 18/WM/0147. Funding This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 23, No. 67. See the NIHR Journals Library website for further project information.

scholarly journals Analysis of virulence factors and antibiotic resistance genes in Group B Streptococcus from clinical samples

2020 ◽  
Author(s):  
Raymond Mudzana ◽  
Rooyen T Mavenyengwa ◽  
Muchaneta Gudza-Mugabe
Keyword(s):  
Antibiotic Resistance ◽  
Pregnant Women ◽  
Virulence Factors ◽  
Resistance Genes ◽  
Virulence Genes ◽  
Group B Streptococcus ◽  
Antibiotic Resistance Genes ◽  
Virulence Gene ◽  
Clinical Samples ◽  
Group B

Abstract Background : Streptococcus agalacticae (Group B Streptococcus, GBS) is one of the most important causative agents of serious infections among neonates. GBS virulence factors are important in vaccine development, whilst antibiotic resistance genes are necessary in understanding the resistance mechanisms used by pathogens. This study was carried out to identify virulence genes and antibiotic resistance genes associated with GBS isolated from pregnant women. Methods: A total of 43 GBS isolates were obtained from 420 vaginal samples collected from HIV positive and negative women who were 13-35 weeks pregnant attending Antenatal Care at Chitungwiza and Harare Central Hospitals in Zimbabwe. Identification tests of GBS isolates was done using standard bacteriological methods including molecular tests. Antibiotic susceptibility testing using 3 antibiotics was done using the modified Kirby-Bauer method. The boiling method was used to extract DNA and Polymerase Chain Reaction (PCR) was used to screen for 13 genes. Data was fed into SPSS 24.0 and the Spearman rank correlation test used to determine correlation among genes. Results: Nine distinct virulence gene profiles were identified. The profiles hly-scpB-bca-rib 37.2% (16/43) and hly-scpB-bca 18.6% (8/43) were common. The following virulence gene frequencies were obtained namely hly 97.8% (42/43), scpB 90.1% (39/43), bca 86.0% (37/43), rib 69.8% (30/43) and bac 11.6% (5/43). High resistance to tetracycline 97.7% (42/43) was reported followed by clindamycin 55.8% (24/43) and erythromycin 30.2% (13/43). Antibiotic resistance genes among the resistant and intermediate-resistant isolates showed high frequencies for tetM 97.6% (41/42) and low frequencies for ermB 34.5% (10/29), ermTR 10.3% (3/29), mefA 3.4% (1/29), tetO 2.4% (1/42) and linB 0% (0/35). The atr housekeeping gene yielded 100% (43/43) positive results, whilst the mobile genetic element IS1548 yielded 9.3% (4/43). Conclusion: The study showed high prevalence of multiple virulence genes hly, scpB, bca and rib in S. agalactiae strains isolated from pregnant women. Tetracycline resistance was found to be predominantly caused by the tetM gene, whilst macrolide resistance was predominantly due to the presence of erm methylase, with the ermB gene being more prevalent. It was also observed that in vitro phenotypic resistance is not always accurately predicted by resistance genotypes.

Sign in / Sign up

Export Citation Format

Share Document